CLINICAL_TRIALS trial_result · 2021-08-04

Clinical Trial Update: Study of Gene Modified Immune Cells in Patients With Advanced Melanoma [Phase 2]

Phase 2 clinical trial update for gene-modified immune cells in patients with metastatic melanoma; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2021-08-04